-
Transforming Diabetes Care through Personalization and Innovation with Lisa Huse
- 2024/10/28
- 再生時間: 35 分
- ポッドキャスト
-
サマリー
あらすじ・解説
In an era where healthcare increasingly embraces personalization, Bradley Bostic and Lisa Huse are at the forefront, advocating for a shift in patient care that’s both effective and tailored. Their conversation isn’t just about innovation; it’s about making healthcare meet the unique needs of each patient. They explore a new kind of patient experience—one where traditional trial-and-error approaches are left behind, replaced by diagnostics and therapies that fit each individual.
Lisa’s extensive experience, particularly in diabetes care with Roche, gives her insights a grounded credibility. She understands that managing diabetes is about more than just medication. As she puts it, “It was about personalization and helping people find their own version of what good looked like.” This isn’t an easy path; the transition from standard methods to personalized care requires shifting entire systems and mindsets, something she and Bradley both passionately advocate for.
When managing diabetes, the challenge goes beyond merely prescribing treatments. Lisa discusses her work with Roche in a world where devices and apps are not always integrated. As she explains, many people face “disparate pieces and parts where one diagnostic product didn't talk to the therapeutic product.” This lack of connectivity can prevent patients from seeing the full picture of their health. It’s here where Lisa saw the potential to change lives—working on models to guide patients toward sustainable behavior changes, which, as she mentions, “feels realistic and something they could accomplish.”
For those navigating diabetes, or any chronic condition, this kind of behavioral support is essential. "Diabetes in many situations is a behavioral disease," Lisa says, stressing that while medication is critical, it isn’t the full solution. She and Bradley explore how success lies in creating a system where patients are motivated by personal goals—like walking a daughter down the aisle—rather than abstract medical advice. The conversation brings into focus the question: How do we enable patients to take control without overwhelming them?
Bradley's interest in this subject isn’t just theoretical. As the founder of hc1, he’s been a transformative figure, guiding his company to become a leader in using AI to analyze lab data, ensuring that each patient gets the treatment they need, at the time they need it. His experience underscores the need for an approach that combines empathy with innovation.
One key topic Lisa highlights is the evolution from clinic-centered care to care at home. Technology is paving the way for home diagnostics and telehealth to improve accessibility and outcomes. As Lisa describes, the future of healthcare is not in prescribing more but in enabling patients to “engage the healthcare community that surrounds you.” It’s a vision where patients work with healthcare professionals in a more collaborative and personalized way—one that doesn’t sacrifice individual needs for a one-size-fits-all solution.
For Lisa and Bradley, the future of healthcare must balance innovation with economic feasibility. Healthcare may be a trillion-dollar industry, but introducing new models of care often meets with financial resistance. As Bradley notes, the industry is a “zero-sum game” where economic incentives are paramount. Without a financial structure that supports innovations like those Lisa champions, the most groundbreaking ideas risk being shelved.
The discussion also underscores the importance of keeping the clinician in the loop. Even with advancements in telehealth and AI, Lisa emphasizes that “diagnosing any condition requires a clinician,” ensuring accuracy and context. This human element, coupled with the power of technology, is where Lisa sees the true potential for change.
As our healthcare system faces shortages of trained...